KPTI - Karyopharm Therapeutics (KPTI) CEO Richard Paulson on Q 2021 Results - Earnings Call Transcript

Karyopharm Therapeutics Inc. (KPTI) Q4 2021 Earnings Conference Call February 8, 2022 8:30 am ET Company Participants Richard Paulson - President, Chief Executive Officer Sohanya Cheng - Chief Commercial Officer Jatin Shah - Chief Medical Officer Michael Mason - Chief Financial Officer Sarah Connors - Vice President, Corporate Communications Conference Call Participants Maury Raycroft - Jefferies Peter Lawson - Barclays Mike Ulz - Morgan Stanley Steve - RBC Capital Markets Eric Joseph - JP Morgan Jonathan Chang - SVB Leerink Ed White - HC Wainwright Arlinda Lee - Canaccord Presentation Operator Good morning. My name is Sara and I will be your conference Operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics fourth quarter and full year 2021 financial results conference call. There will be a question and answer session to follow. Please be advised that this call is being recorded at the company’s

For further details see:

Karyopharm Therapeutics (KPTI) CEO, Richard Paulson on Q 2021 Results - Earnings Call Transcript